Observed in all serial MM samples was the presence of a RAS gene species (NRAS, KRAS) with a hotspot mutation, known to provide a similar oncogenic signal/activation of the MAPK pathway promoting aberrant cellular proliferation. The gene discussed is KRAS; the disease is Miyoshi myopathy.